Flagship is part of Akoya’s global network of qualified CRO service providers.
As a Gold Sponsor for Spatial Biology East Coast Congress, thank you for joining us and see you next year.
We're exhibiting at the 14th World Clinical Biomarkers & CDx Summit Sept. 4-6 in Boston.
SPATIALPlex™ SOLUTIONS
AN INNOVATIVE APPROACH TO YOUR BIOMARKER AND CLINICAL DEVELOPMENT PROGRAM
DEFINE, DEVELOP, EXECUTE
Since 2009, we’ve led the way in spatial biology, being among the first to utilize machine learning and AI for spatial analysis and establishing ourselves as the most dependable partner for your clinical program. We bring you cutting-edge technologies from industry-leading partners.
Flagship Biosciences is proud to be a CLIA-certified and CAP-accredited laboratory. This demonstrates our commitment to maintaining the highest standards of quality and accuracy in laboratory testing and analysis.
ADVANCING YOUR
BIOMARKER PROGRAM
In rare disease, oncology and other therapeutic areas, Flagship can develop, validate and operationalize complex assays. Flagship has an extensive library of validated singleplex, duplex and multiplex panels for client use. Our expertise in biomarker discovery ensures precise and reliable results for your clinical trials.
FLAGSHIP DATA SCIENCE
Streamline spatial analysis through the power of AI with a consultative approach
Our approach involves collecting and analyzing over a thousand data points per cell, employing a combination of proprietary and open-source data analysis tools. With the expertise of our seasoned Data Science Team, we provide insightful answers that inform critical decisions in therapeutic development and translational science. Our method seamlessly integrates results derived from spatial proteomic and genomic data, enhancing the depth and breadth of our analyses.
Flagship is part of Akoya’s global network of qualified CRO service providers.
As a Gold Sponsor for Spatial Biology East Coast Congress, thank you for joining us and see you next year.
We're exhibiting at the 14th World Clinical Biomarkers & CDx Summit Sept. 4-6 in Boston.
ADVANCING YOUR BIOMARKER PROGRAM
In rare disease, oncology and other therapeutic areas, Flagship can develop, validate and operationalize complex assays. Flagship has an extensive library of validated singleplex, duplex and multiplex panels for client use. Our expertise in biomarker discovery ensures precise and reliable results for your clinical trials.
FLAGSHIP DATA SCIENCE
Streamline spatial analysis through the power of AI with a consultative approach
Our approach involves collecting and analyzing over a thousand data points per cell, employing a combination of proprietary and open-source data analysis tools. With the expertise of our seasoned Data Science Team, we provide insightful answers that inform critical decisions in therapeutic development and translational science. Our method seamlessly integrates results derived from spatial proteomic and genomic data, enhancing the depth and breadth of our analyses.
Spatial Biology Expertise
Guiding Translational Decisions
SPATIALPlex SOLUTIONS – Flagship’s spatial biology platform is comprised of an integrated team of scientists, cutting-edge bioinformaticians and a legacy of pathology expertise. Our advancements in spatial biology allow for comprehensive tissue analysis that supports drug development.
With seventeen US patents backing our proprietary image analysis technology, Flagship partners with you to deliver customized data to meet your unique needs. Starting with assessment and determining the correct modalities, our dedicated and collaborative scientific and project management teams provide end-to-end support throughout the entire process, from pre-IND to commercialization.
Our commitment to translational science bridges the gap between laboratory research and clinical application, ensuring that our findings translate into meaningful patient outcomes.
Multiplex IHC and In Situ Hybridization are powerful diagnostic tools that enable the simultaneous detection of multiple biomarkers in a single sample. Flagship Biosciences offers a comprehensive service that includes the development, validation, and execution of multiplex IHC, FISH, and CISH assays that can detect up to six biomarkers per sample. Our state-of-the-art technology and expertise in the field enable us to provide accurate and reliable results that can help inform clinical decisions and support drug development programs. With Flagship Biosciences, you can trust that your multiplex assays are in the hands of experienced professionals who are dedicated to delivering the highest quality service possible.
Flagship provides a range of genomic analysis services that encompass various techniques and applications. Our team of experts is well-equipped and proficient in handling diverse forms of genomic analysis, including full genome sequencing, RNA sequencing, spatial transcriptomics, and methylation sequencing. We utilize state-of-the-art technologies and advanced methods to ensure that our results are accurate and reliable. Furthermore, our molecular extraction capabilities are robust, allowing us to work with a diverse range of sample types and formats. Whether you are engaged in basic research or drug development, our genomics services offer valuable insights to help you achieve your goals. You can trust Flagship Biosciences to offer the highest quality results and support for all your genomic analysis needs.
Our scientific and medical teams are experienced in flow cytometry assessments supporting many applications including hematopoietic neoplasms, MRD, receptor occupancy, expansive immunophenotyping, and Immuno-oncology assessments.
Flagship Biosciences has developed a state-of-the-art digital pathology and image analysis department that is staffed by a team of highly skilled professionals. Our experts utilize our proprietary artificial intelligence software, Flotilla, to create customized deep-learning solutions that cater to your target disease states and biomarkers.
Our capable data science group specializes in sophisticated multi-omic projects. We possess the expertise required to seamlessly integrate disparate data sets into holistic conclusions that offer valuable insights for your research project. We utilize advanced methodologies and cutting-edge technology to deliver the comprehensive and accurate answers your program requires.